Evidence map›Paper›PMID 40637102›Full record

ArticleInternational journal of cosmetic science2025

PEG-23 glyceryl distearate, a multifunctional skin-supporting material, upregulates the expression of factors associated with epidermal barrier and hydration.

Tatsuro Miyoshi, Brian C Keller, Sui Nakagawa, Takashi Ashino, Satoshi Numazawa

Abstract read
In one paragraph

Article in International journal of cosmetic science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatsuro MiyoshiBeverly Glen Laboratories, Inc., Newport Beach, California, USA.ORCID https://orcid.org/0009-0009-6578-7709
Brian C KellerBeverly Glen Laboratories, Inc., Newport Beach, California, USA.
Sui NakagawaDepartment of Toxicology, Showa Medical University Graduate School of Pharmacy, Shinagawa, Tokyo, Japan.
Takashi AshinoDepartment of Toxicology, Showa Medical University Graduate School of Pharmacy, Shinagawa, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4402-0989
Satoshi NumazawaDepartment of Toxicology, Showa Medical University Graduate School of Pharmacy, Shinagawa, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4818-1061

Funding

Beverly Glen Laboratories, Inc.
6 · The paper itself

Abstract

objectiveAs the outermost organ of the human body, the skin plays a critical role in protecting against external agents and oxidative stress, as well as in preventing excessive water loss. Among its layers, the stratum corneum of the epidermis is central to both barrier function and moisture retention, with its structural integrity significantly influencing skin health and appearance. Polyethylene glycol-23 glyceryl distearate (GDS-23) can form niosomes, liposome-like structures with multiple layers and serve as a carrier in drug delivery systems (DDS). We previously reported that GDS-23 exerts multiple biological effects, suppressing inflammation and enhancing the endogenous antioxidant system via Nrf2 activation through phosphorylation of the autophagy adaptor protein p62. In this study, we investigated the effects of GDS-23 on epidermal barrier function and moisture retention using normal human epidermal keratinocytes (NHEKs) and a three-dimensional (3D) epidermal model, mimicking human skin structure.

methodsNHEKs and the 3D epidermal model were treated with GDS-23. Gene expression in NHEKs was analysed using real-time polymerase chain reaction, while the levels of epidermal barrier- and moisture retention-related factors in the 3D model were evaluated using immunofluorescence staining.

resultsTreatment with GDS-23 upregulated the mRNA expression of genes involved in stratum cornea formation (filaggrin and loricrin), moisture retention (aquaporin 3 and hyaluronan synthase 3) and intercellular lipid synthesis (ceramide synthase, sulfotransferase 2B1 and peroxisome proliferator-activated receptor α) in NHEKs. Additionally, treatment with K67, which inhibits p62 phosphorylation and thereby suppresses Nrf2 activation via a non-canonical mechanism, suppressed the GDS-23-induced expression of filaggrin, loricrin, ceramide synthase, sulfotransferase 2B1 and aquaporin 3. In the 3D epidermal model, GDS-23 treatment upregulated the expression of Nrf2, downstream antioxidant factors and proteins involved in stratum corneum formation and moisture regulation. Mechanistically, GDS-23 enhanced endogenous antioxidant function and modulated the expression of molecular markers associated with epidermal barrier and moisture retention, thereby potentially contributing to skin homeostasis.

conclusionAs GDS-23 contributes to the maintenance of skin homeostasis, it is expected to have future applications in the cosmetic field and in the treatment of skin disorders. Overall, GDS-23 holds promise as a "multifunctional DDS material" that promotes skin health.

Indexed as

EpidermisPolyethylene GlycolsUp-RegulationFilaggrin ProteinsHumansKeratinocytesWaterFilaggrin ProteinsPolyethylene GlycolsWaterbarrier functionepidermal keratinocyteGDS‐23hydrationmultifunctional DDS materialskin health

Identifiers

PMID40637102
PMCPMC12666733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.